Evaluation of a telemedicine pilot program for the provision of HIV pre-exposure prophylaxis in the Southeastern United States

References

• Bernocchi, P., Baratti, D., Zanelli, E., Rocchi, S., Salvetti, M., Paini, S., & Scalvini, S. (2011). Six-month program on lifestyle changes in primary cardiovascular prevention: A telemedicine pilot study. The European Journal of Cardiovascular Prevention & Rehabilitation, 18(3), 481–487. https://doi.org/10.1177/1741826710389364
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). (2014, May). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014 clinical practice guideline. Retrieved February 6, 2017, from https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2019, August). Pre-exposure prophylaxis (PrEP). Retrieved September 19, 2019, from https://www.cdc.gov/hiv/risk/prep/index.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2020a, May). Estimated HIV incidence and prevalence in the United States, 2014–2018. Retrieved January 12, 2021, from https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-1.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2020b, May). HIV Surveillance Report, 2018 (Updated); vol. 31. Retrieved January 28, 2021, from https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Chin, B., Porter, A., Kurywach, D., & John, M. (2012). An Urban HIV Telemedicine program for specialty HIV services for underserved populations in San Fransisco. The Positive Care Center at UCSF. Retrieved February 6, 2017, from http://www.hivforum.org/storage/documents/HealthDisparities/2012/Slides/Wednesday/PM/13_chinv2.pdf
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., Vanichseni, S., & Bangkok Tenofovir Study Group. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomized, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Christensen, H., Batterham, P. J., & O'Dea, B. (2014). E-health interventions for suicide prevention. International Journal of Environmental Research and Public Health, 11(8), 8193–8212. https://doi.org/10.3390/ijerph110808193
   PubMed Web of Science ®Google Scholar
• de Tolly, K., Skinner, D., Nembaware, V., & Benjamin, P. (2012). Investigation into the use of short message services to expand uptake of human immunodeficiency virus testing, and whether content and dosage have impact. Telemedicine Journal and e-Health, 18(1), 18–23. https://doi.org/10.1089/tmj.2011.0058
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., Buchbinder, S., Veloso, V. G., Mayer, K., Chariyalertsak, S., Bekker, L. G., Kallas, E. G., Schechter, M., Guanira, J., Bushman, L., Burns, D. N., … iPrEx study team.(2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829. https://doi.org/10.1016/S1473-3099(14)70847-3
   PubMed Web of Science ®Google Scholar
• Haberer, J. E. (2016). Current concepts for PrEP adherence in the PrEP revolution: From clinical trials to routine practice. Current Opinion in HIV and AIDS, 11(1), 10–17. https://doi.org/10.1097/COH.0000000000000220
   PubMed Web of Science ®Google Scholar
• Hoth, A. B., Shafer, C., Dillon, D. B., Mayer, R., Walton, G., & Ohl, M. E. (2019). Iowa TelePrEP: A public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state. Sexually Transmitted Diseases, 46(8), 507–512. https://doi.org/10.1097/OLQ.0000000000001017
   PubMed Web of Science ®Google Scholar
• Jaén, C. R., Stange, K. C., & Nutting, P. A. (1994). Competing demands of primary care: A model for the delivery of clinical preventive services. The Journal of Family Practice, 38(2), 166–171.
   PubMed Web of Science ®Google Scholar
• Knobel, H., Alonso, J., Casado, J. L., Collazos, J., González, J., Ruiz, I., Kindelan, J. M., Carmona, A., Juega, J., Ocampo, A., & GEEMA Study Group. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. AIDS. 16(4): 605-613. https://doi.org/10.1097/00002030-200203080-00012
   PubMed Web of Science ®Google Scholar
• Nunn, A. S., Brinkley-Rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017). Defining the HIV pre-exposure prophylaxis care continuum. AIDS (London, England), 31(5), 731–734. https://doi.org/10.1097/QAD.0000000000001385
   PubMed Web of Science ®Google Scholar
• Pietrzak, E., Cotea, C., & Pullman, S. (2014). Primary and secondary prevention of cardiovascular disease: Is there a place for internet-based interventions? Journal of Cardiopulmonary Rehabilitation and Prevention, 34(5), 303–317. https://doi.org/10.1097/HCR.0000000000000063
   PubMed Web of Science ®Google Scholar
• Refugio, O. N., Kimble, M. M., Silva, C. L., Lykens, J. E., Bannister, C., & Klausner, J. D. (2019). Brief report: PrEPTECH: A telehealth-based initiation program for HIV pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility. Journal of Acquired Immune Deficiency Syndromes, 80(1), 40–45. https://doi.org/10.1097/QAI.0000000000001873
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., Koenig, L. J., & Valleroy, L. A. (2015). Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morbidity and Mortality Weekly Report, 64(46), 1291–1295. https://doi.org/10.15585/mmwr.mm6446a4
   PubMed Web of Science ®Google Scholar
• Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., Castel, A. D., Yeung, H., Kramer, M., McCallister, S., & Siegler, A. J. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology, 28(12), 833–840. https://doi.org/10.1016/j.annepidem.2018.06.009
   PubMed Web of Science ®Google Scholar
• Thirumurthy, H., & Lester, R. T. (2012). M-Health for health behavior change in resource-limited settings: Applications to HIV care and beyond. Bulletin of the World Health Organization, 90(5), 390–392. https://doi.org/10.2471/BLT.11.099317
   PubMed Web of Science ®Google Scholar
• Widmer, R. J., Collins, N. M., Collins, C. S., West, C. P., Lerman, L. O., & Lerman, A. (2015). Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clinic Proceedings, 90(4), 469–480. https://doi.org/10.1016/j.mayocp.2014.12.026
   PubMed Web of Science ®Google Scholar
• Wong, K. Y. K., Stafylis, C., & Klausner, J. D. (2020). Telemedicine: A solution to disparities in human immunodeficiency virus prevention and pre-exposure prophylaxis uptake, and a framework to scalability and equity. Mhealth, 6, 21. https://doi.org/10.21037/mhealth.2019.12.06
   PubMedGoogle Scholar
• Young, J. D., Patel, M., Badowski, M., Mackesy-Amiti, M. E., Vaughn, P., Shicker, L., Puisis, M., & Ouellet, L. J. (2014). Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: An observational study with historical controls. Clinical Infectious Diseases, 59(1), 123–126. https://doi.org/10.1093/cid/ciu222
   PubMed Web of Science ®Google Scholar